Wells Fargo downgraded Affimed (AFMD) to Equal Weight from Overweight with a price target of 10c, down from $11, following the announcement that the company is opening insolvency proceedings given that the company’s liquidity condition raises substantial doubt about its ability to continue as a going concern. Though there is value in acimtamig, the small market opportunity likely has limited the company’s ability to access capital, the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AFMD: